The pharmacology of cyclopropyl-methoxycarbonyl metomidate: A comparison with propofol

Anesthesia and Analgesia

Volumn 118, Issue 3, 2014, Pages 563-567

  Ge, Rile ^a   Pejo, Ervin ^b   Gallin, Hilary ^c   Jeffrey, Spencer ^b   Cotten, Joseph F ^a   Raines, Douglas E ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALPHA1(L264T)BETA3GAMMA2 GAMMA AMINOBUTYRIC ACID A RECEPTOR; CYCLOPROPYL METHOXYCARBONYL METOMIDATE; METOMIDATE; PROPOFOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN RADIOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG POTENCY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; XENOPUS LAEVIS;

ANESTHETICS, INTRAVENOUS; ANIMALS; ELECTROENCEPHALOGRAPHY; ETOMIDATE; FEMALE; LARVA; MALE; PROPOFOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; REFLEX, RIGHTING; XENOPUS LAEVIS;

EID: 84896837197     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000069     Document Type: Article

References (19)

1. Edbrooke DL, Newby DM, Mather SJ, Dixon AM, Hebron BS. Safer sedation for ventilated patients. A new application for etomidate. Anesthesia 1982;37:765-71
2. Lindeburg T, Spotoft H, Bredgaard Sørensen M, Skovsted P. Cardiovascular effects of etomidate used for induction and in combination with fentanyl-pancuronium for maintenance of anesthesia in patients with valvular heart disease. Acta Anesthesiol Scand 1982;26:205-8
3. Lees NW, Glasser J, McGroarty FJ, Miller BM. Etomidate and fentanyl for maintenance of anesthesia. Br J Anesth 1981;53:959-61
4. Watt I, Ledingham IM. Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anesthesia 1984;39:973-81
5. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D. Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984;310:1415-21
6. De Jong FH, Mallios C, Jansen C, Scheck PA, Lamberts SW. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation. J Clin Endocrinol Metab 1984;59:1143-7
7. Ledingham IM, Watt I. Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983;1:1270
8. Husain SS, Pejo E, Ge R, Raines DE. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action. Anesthesiology 2012;117:1027-36
9. Pejo E, Cotten JF, Kelly EW, Le Ge R, Cuny GD, Laha JK, Liu J, Lin XJ, Raines DE. In vivo and in vitro pharmacological studies of methoxycarbonyl- carboetomidate. Anesth Analg 2012;115:297-304
10. Cotten JF, Le Ge R, Banacos N, Pejo E, Husain SS, Williams JH, Raines DE. Closed-loop continuous infusions of etomidate and etomidate analogs in rats: A comparative study of dosing and the impact on adrenocortical function. Anesthesiology 2011;115:764-73
11. Cotten JF, Husain SS, Forman SA, Miller KW, Kelly EW, Nguyen HH, Raines DE. Methoxycarbonyl-etomidate: A novel rapidly metabolized and ultra-short-Acting etomidate analogue that does not produce prolonged adrenocortical suppression. Anesthesiology 2009;111:240-9
12. Ge R, Pejo E, Cotten JF, Raines DE. Adrenocortical suppression and recovery after continuous hypnotic infusion: Etomidate versus its soft analogue cyclopropyl-methoxycarbonyl metomidate. Crit Care 2013;17:R20
13. Pejo E, Ge R, Banacos N, Cotten JF, Husain SS, Raines DE. Electroencephalographic recovery, hypnotic emergence, and the effects of metabolite after continuous infusions of a rapidly metabolized etomidate analog in rats. Anesthesiology 2012;116:1057-65
14. Ge R, Pejo E, Husain SS, Cotten JF, Raines DE. Electroencephalographic and hypnotic recoveries after brief and prolonged infusions of etomidate and optimized soft etomidate analogs. Anesthesiology 2012;117:1037-43
15. Ge RL, Pejo E, Haburcak M, Husain SS, Forman SA, Raines DE. Pharmacological studies of methoxycarbonyl etomidate's carboxylic acid metabolite. Anesth Analg 2012;115:305-8
16. Wittmer LL, Hu Y, Kalkbrenner M, Evers AS, Zorumski CF, Covey DF. Enantioselectivity of steroid-induced gamma-Aminobutyric acidA receptor modulation and anesthesia. Mol Pharmacol 1996;50:1581-6
17. Servin F, Desmonts JM, Haberer JP, Cockshott ID, Plummer GF, Farinotti R. Pharmacokinetics and protein binding of propofol in patients with cirrhosis. Anesthesiology 1988;69:887-91
18. Gin T, Yau G, Jong W, Tan P, Leung RK, Chan K. Disposition of propofol at cesarean section and in the postpartum period. Br J Anesth 1991;67:49-53
19. Meuldermans WE, Heykants JJ. The plasma protein binding and distribution of etomidate in dog, rat and human blood. Arch Int Pharmacodyn Ther 1976;221:150-62